Chloride homeostasis

Chloride homeostasis refers to the tightly regulated balance of chloride ions (Cl^-) within and outside cells, crucial for maintaining osmotic pressure, electrical neutrality, acid-base balance, neuronal excitability, and muscle function[3][4][6]. This process is mediated by a variety of chloride channels (e.g., CLC family, CFTR), cation-chloride cotransporters (especially KCC2 and NKCC1 in neurons), exchangers (such as the SLC4 and SLC26 families), and neurotransmitter-gated receptors (notably GABA_A and glycine receptors)[3][6][4]. Dysregulation of chloride homeostasis is implicated in multiple diseases, including epilepsy, cystic fibrosis, and renal and neurological disorders[4][6][7]. Pharmacological targeting of certain transporters or channels (such as NKCC1 with bumetanide, KCC2 with VU0463271, or CFTR modulators in cystic fibrosis) can modulate aspects of chloride homeostasis for therapeutic intent[5][6][4]. In summary, "Chloride homeostasis" is not a specific druggable target, and should be disambiguated into the actual channels, cotransporters, or regulatory molecules (e.g., CFTR, KCC2, NKCC1, GABA_A receptor) relevant for the biological or therapeutic context[3][4][6][7].

Other names

Chloride regulationChloride ion balanceCl^- homeostasis

Drugs affecting chloride homeostasis primarily act through inhibition or activation of chloride channels, inhibition or activation of cation-chloride cotransporters (e.g., NKCC1, KCC2), and modulation of GABA_A receptor activity (indirectly affecting Cl^- flux).